Joint Research Promotion Program (JRPP) in Wako
In order to promote joint research (especially within CSRS), we will present the advanced technologies of the "Advanced Research and Technology Platforms" and consult on joint research.
- This is a service for CSRS. Please contact us if you are outside.
- Summary of JRPP Utilization and Outcome Papers
Utilization / Published Papers
- News
- Chemicals and small molecules
- High-throughput screening
- Proteins and supermolecules
- Molecular interactions
- Equipments
- Persons in charge
- Contact us
News
- A kick-off meeting of JRPP was held on the 19th Nov. Each person in charge introduced the activity.
:This is a box file link that can be used only within RIKEN.
Chemicals and small molecules
- Diverse chemical library provision for High Throughput Screening (HTS) (Mr Hirano)
- Provision of chemical libraries for efficient compound screening (Mr Hirano)
- Authentic library (80 Highly active compounds)
- Pilot library (Typical 400 chemotype compounds)
- Bioactive focused chemical Libraries
- Support of Information Search related to hit compounds (Mr Hirano) (published literature, novelty, purchase potential)
- Support of compound similarity search for analogs of hit compounds and provision of these compounds (Mr Hirano) (Comparison among a large number of compound groups, a number of compounds structure search for the NPDepo library and selection of duplicate compounds)
- Structural classification for the hit compounds set by hierarchical clustering method (Mr Hirano)
- 2DE-based proteomic analysis of proteins changed in thermal stability by binding to a compound (2DE-CETSA) (Dr Muroi)
- Making chemical beads for target identification (Dr Kawatani)
- Synthesis of bioactive compounds (Dr Hagihara)
- Chemical tools that accelerate plant science (Dr Hagihara)
- Mass spectrometry in the qualitative and quantitative analysis of organic compounds (Dr Muranaka) (including but not limited to: accurate mass measurement and deduction of molecular mass and formula, analysis of unstable compounds including air-sensitive ones, analysis of volatile compounds including volatile derivatives, method development for qualitative and/or quantitative mass spectrometry, structural characterization based on tandem mass spectrometry and ion mobility spectrometry, analysis and characterization of isomers, direct ionization from solid and MS imaging by desorption electrospray ionization, separation by supercritical fluid chromatography for MS analysis)
- Measurement and analysis of NMR spectra (Dr Muranaka) (structural characterization of organic compounds using NMR spectroscopy, measurement of several NMR experiments,quantitative NMR analysis, measurement and analysis of solid-state NMR spectra, measurement of micro magnetic resonance imaging)
- Measurement and analysis of circular dichroism spectra (Dr Muranaka)
- Measurement and analysis of UV-vis-NIR, IR, and fluorescence spectra (Dr Muranaka)
- Measurement of cyclic voltammograms (Dr Muranaka)
- Molecular structure analysis based on quantum chemical calculations (Dr Muranaka)
- Determination of absolute configuration of organic compounds based on organic synthesis and asymmetric total synthesis (Dr Muranaka)
- Structural analyses based on organic synthesis (Dr Muranaka)
- Chemoenzymatic synthesis of co-factor related compounds (Dr Awakawa)
High-throughput screening
- Target identification of small molecules and functional genomics with shRNA screening and CRISPR screening in human cells (Dr Matsumoto)
- Assay development for High-throughput screening (HTS) and High-content screening (HCS) (Dr Idei)
- Target identification based on yeast chemical genomics analysis (Dr Yashiroda)
- High-throughput screening for protein-binding small molecules (ligands) using chemical array (Dr Kawatani)
Proteins and supermolecules
- Quantitative Proteomics (Dr Dohmae)
- Protein post-translational modifications analysis (Dr Dohmae)
- Identification of binding site of the compounds in protein (Dr Dohmae)
- Characterization of RNA and therapeutic oligonucleotides using MS (Dr Dohmae)
- Protein absolute quantification using amino acid analysis (Dr Dohmae)
- Mass spectrometry of compounds and macromolecules including determination of exact mass (Dr Dohmae)
- Purification and analysis using HPLC (Dr Dohmae)
- X-ray crystallography (Dr Kudo)
- Protein knockdown by AID system (Dr Hagihara)
Molecular interactions
- Interaction analysis using NanoBiT (Split Luc) (Dr Sasaki)
- Binding affinity measurement of biomolecular interactions by Microscale Thermophoresis (MST) (Mr Matsuoka)
- Kinetics analysis of biomolecular interactions by Surface Plasmon Resonance (SPR) (Mr Matsuoka)
- Thermodynamic analysis of biomolecular interactions by Isothermal Titration Calorimetry (ITC) (Mr Matsuoka)
- Evaluation of protein stability by Nano Differential Scanning Fluorimetry (nanoDSF) (Mr Matsuoka)
Equipments
2DE-based proteome analysis system (Dr Muroi)
High Throughput DNA Purification instrument (Dr Yashiroda)
Quantitative Proteomics・ Protein post-translational modifications analysis (Dr Dohmae)
Protein absolute quantification using amino acid analysis (Dr Dohmae)
Purification and analysis using HPLC (Dr Dohmae)
Stereomicroscope and calculator (Dr Kudo)
Persons in charge
- Dr Ken Matsumoto ( Chemical Genomics Research Group )
- Dr Kazuki Sasaki ( Chemical Genomics Research Group )
- Dr Norio Kudo ( Chemical Genomics Research Group )
- Dr Yoko Yashiroda ( Molecular Ligand Target Research Team )
- Dr Takayoshi Awakawa ( Chemical Biology and Biosynthesis Research Team )
- Dr Makoto Kawatani ( Biomolecular Characterization Unit / Chemical Resource Development Research Unit | Technology Platform Division )
- Dr Makoto Muroi ( Biomolecular Characterization Unit / Chemical Resource Development Research Unit | Technology Platform Division )
- Mr Seiji Matsuoka( Drug Discovery Seed Compounds Exploratory Unit | Drug Discovery Platforms Cooperation Division )
- Dr Akiko Idei ( Drug Discovery Seed Compounds Exploratory Unit | Drug Discovery Platforms Cooperation Division )
- Mr Hiroyuki Hirano ( Drug Discovery Chemical Bank Unit | Drug Discovery Platforms Cooperation Division )
- Dr Shinya Hagihara ( Molecular Bioregulation Research Team )
- Dr Atsuya Muranaka ( Molecular Structure Characterization Unit | Technology Platform Division )
- Dr Naoshi Dohmae ( Biomolecular Characterization Unit | Technology Platform Division )
Contact us
It is in trial operation. Please contact us by email at CSRScollabo [at] ml.riken.jpWe will contact you for a meeting on Zoom.